1192145-72-4

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 934543-00-7 5-(4-(2-fluoro-5-methylpyridne-3-yl)-methoxybenzene)-1,3-diamine 
• 89694-44-0 (2-bromo-5-methoxyphenyl)boronic acid 
• 153034-78-7 2-Fluoro-3-iodo-5-methylpyridine 
• 934543-02-9 tert-butyl 5-bromo-7-(tert-butoxycarbonylamino)-8-methoxy-3-methyl-9H-pyrido[2,3-b]indole-9-carboxylate 
• 934542-99-1 3-(6-bromo-3-methoxy-2,4-dinitrophenyl)-2-fluoro-5-methylpyridine 
• 934542-98-0 3-(2-bromo-5-methoxyphenyl)-2-fluoro-5-methyl-pyridine 
• 934543-01-8 5-bromo-8-methoxy-3-methyl-9H-pyrido[2,3-b]indol-7-amine 
• 845870-47-5 [3-(ethanesulfonyl)phenyl]boronic acid 
• 934543-03-0 tert-butyl 5-bromo-7-(tert-butoxycarbonyl(methyl)amino)-8-methoxy-3-methyl-9H-pyrido[2,3-b]indole-9-carboxylate 

Relevant academic research and scientific papers

KINASE INHIBITORS

Compounds are provided for use with kinases that comprise a compound selected from the rou consistin of:wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods an intermediates useful for making the compounds; and methods of using said compounds.

KINASE INHIBITORS

Compounds, pharmaceutical compositions, kits and methods are provided for use with kinases that comprise a compound selected from the group consisting of formula (I) wherein the variables are as defined herein.